Nabeel Khan, MD
Assistant Clinical Professor of Medicine
Director Inflammatory Bowel Disease
Dr. Khan received his medical degree from King Edwards Medical College in Pakistan. He went on to complete his residency in internal medicine at Mercy Catholic Medical Center in Philadelphia, PA. He completed his fellowship in Gastroenterology from Louisiana State University. He was trained in ERCP’s and has special interest in motility studies. He worked in a private practice group in Memphis, TN and later became an Instructor at SUNY Brooklyn School of Medicine.
Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: A meta-analysis of clinical trials. Khan N, Abbas AM, Whang N, Balart LA, Bazzano LA, Kelly TN.Inflamm Bowel Dis. 2011 Jul 12. doi: 10.1002/ibd.21820. [Epub ahead of print].
Atypical GERD symptoms are often not due to reflux shown by PH monitor. N. Khan, R. Gideon, P. Katz, D. Castell. American Journal of Gastroenterology, Sep 2000 Supplement (Abstract).
Factors predicting a positive hepatitis panel in a community hospital setting, N. Khan, G. Tadros, S. Singh, J. Abrams, W. Paine. American Journal of Gastroenterology. Sep 2000 Supplement (Abstract).
Multiple liver abscesses due to Yersinia enterocolitica reveal hereditary hemochromatosis. N. Khan, R. Hally, L. Balart. American Journal of Gastroenterology, Sep 2001 Supplement (Abstract).
Low yield of screening for Barrett’s esophagus in patients with a history of gastroesophageal reflux in a university hospital setting. N. Khan, B. Ruiz, L. Balart. American Journal of Gastroenterology, Sep 2002 Supplement(Abstract).
Maintenance therapy with Infliximab in the management of fistulous Crohn’s disease. N. Khan, T. Huynh Le, L. Balart. American Journal of Gastroenterology, Sep 2002 Supplement (Abstract).
1430 Tulane Ave, New Orleans, LA 70112 504-988-5187 email@example.com